• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HCV genetics and genotypes dictate future antiviral strategies.丙型肝炎病毒(HCV)的遗传学和基因型决定了未来的抗病毒策略。
J Mol Biochem. 2017;6:33-40. Epub 2017 Dec 10.
2
Burden of pediatric hepatitis C.儿童丙型肝炎负担。
World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880.
3
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
4
Characteristics of Hepatitis B Virus, Hepatitis C Virus, and Syphilis Coinfection in People With HIV/AIDS Contracted Through Different Sources: Retrospective Study.乙型肝炎病毒、丙型肝炎病毒和梅毒合并感染在不同途径感染人类免疫缺陷病毒/艾滋病患者中的特征:回顾性研究。
JMIR Public Health Surveill. 2024 Feb 27;10:e46750. doi: 10.2196/46750.
5
Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.乌干达坎帕拉联合临床研究中心诊所(JCRC)就诊的HIV感染患者中乙型和丙型肝炎的患病率及其与肝损伤的关系。
Afr Health Sci. 2015 Jun;15(2):322-7. doi: 10.4314/ahs.v15i2.3.
6
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.附录:美国国立卫生研究院2002年丙型肝炎共识发展会议管理办法
Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8.
7
Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China.中国广西地区HIV感染患者丙型肝炎病毒的检测与分析
Exp Ther Med. 2017 Mar;13(3):917-923. doi: 10.3892/etm.2017.4067. Epub 2017 Jan 20.
8
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第1部分:重症丙型肝炎和注射者数据。
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
9
Hepatitis and HIV infection during haemodialysis.血液透析期间的肝炎与HIV感染
J Indian Med Assoc. 2001 Apr;99(4):194-9, 203, 213.
10
Hepatitis B and C and renal failure.乙型和丙型肝炎与肾衰竭。
Infect Dis Clin North Am. 2001 Sep;15(3):877-99. doi: 10.1016/s0891-5520(05)70177-x.

本文引用的文献

1
A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses.伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)中的一系列Notch3突变:来自三维分子建模和进化分析的见解
J Mol Biochem. 2014;3(3).
2
Ebola virus epidemic: a deliberate accident?埃博拉病毒疫情:一场蓄意事故?
J Mol Biochem. 2014;3(3):72-76.
3
Molecular dynamics simulations through GPU video games technologies.通过GPU视频游戏技术进行分子动力学模拟。
J Mol Biochem. 2014;3(2):64-71. Epub 2014 Jun 30.
4
An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.黄病毒科NS3解旋酶和NS5 RNA依赖性RNA聚合酶的最新进化研究揭示了作为潜在药理学靶点的新型保守基序。
Mol Biosyst. 2016 Jun 21;12(7):2080-93. doi: 10.1039/c5mb00706b.
5
Structural models for the design of novel antiviral agents against Greek Goat Encephalitis.针对希腊山羊脑炎的新型抗病毒药物设计的结构模型。
PeerJ. 2014 Nov 6;2:e664. doi: 10.7717/peerj.664. eCollection 2014.
6
Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.利用 RNA 干扰 (RNAi) 技术对抗 HIV-1 的抗病毒策略。
Evol Bioinform Online. 2013 May 16;9:203-13. doi: 10.4137/EBO.S11412. Print 2013.
7
A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase.全面的进化和结构研究为丙型肝炎病毒解旋酶的功能和抑制提供了深入了解。
PeerJ. 2013 May 7;1:e74. doi: 10.7717/peerj.74. Print 2013.
8
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.通过从头药物设计方法发现一种新型丙型肝炎病毒解旋酶抑制剂。
Bioorg Med Chem Lett. 2009 Jun 1;19(11):2935-7. doi: 10.1016/j.bmcl.2009.04.074. Epub 2009 Apr 22.
9
The hepatitis C virus epidemic among injecting drug users.注射吸毒者中的丙型肝炎病毒流行情况。
Infect Genet Evol. 2005 Mar;5(2):131-9. doi: 10.1016/j.meegid.2004.08.001.
10
Control of hepatitis C: a medicinal chemistry perspective.
J Med Chem. 2005 Jan 13;48(1):1-20. doi: 10.1021/jm0400101.

丙型肝炎病毒(HCV)的遗传学和基因型决定了未来的抗病毒策略。

HCV genetics and genotypes dictate future antiviral strategies.

作者信息

Papageorgiou Louis, Vlachakis Chrisanthy, Dragoumani Konstantina, Raftopoulou Sofia, Brouzas Dimitrios, Nicolaides Nicolas C, Chrousos George P, Charmandari Evangelia, Megalooikonomou Vasileios, Vlachakis Dimitrios

机构信息

Department of Informatics and Telecommunications, National and Kapodistrian University of Athens, University Campus, Athens 15784, Greece.

Department of Medicine, National and Kapodistrian University of Athens, 75, M. Assias Street, Athens 11527, Greece.

出版信息

J Mol Biochem. 2017;6:33-40. Epub 2017 Dec 10.

PMID:29387656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788192/
Abstract

At the end of the 1980s, the hepatitis C virus (HCV) was cloned and formally identified as the cause of the majority of non-A and non-B hepatitis cases. Today, around 170 million people worldwide are infected with HCV, making it five times more common than infection with the human immunodeficiency virus (HIV). Several methods exist which mediate the spread of infection. One of the most common and efficient is sharing or re-using injecting equipment; studies have indicated that 80-90% of individuals in some populations of intravenous drug users test positive in serum HCV assays. Contracting HCV from infected blood transfusions was also a major cause of infection before screening tests were introduced in the early 1990s. Other possible, but less common, methods of infection transmission include mother-to-child during pregnancy, sexual contact and nosocomial acquisition (for example between surgical or dialysis patients). It appears that concurrent HIV-1 infection increases the risk of HCV transmission via the mother-to-child or sexual routes.

摘要

20世纪80年代末,丙型肝炎病毒(HCV)被克隆并被正式确认为大多数非甲非乙型肝炎病例的病因。如今,全球约有1.7亿人感染了HCV,这使其感染率比人类免疫缺陷病毒(HIV)感染率高出四倍。存在多种介导感染传播的方式。最常见且有效的方式之一是共用或重复使用注射设备;研究表明,在一些静脉吸毒人群中,80%至90%的个体血清HCV检测呈阳性。在20世纪90年代初引入筛查检测之前,因输入受感染血液而感染HCV也是一个主要感染原因。其他可能但不太常见的感染传播方式包括孕期母婴传播、性接触和医院内感染(例如在手术或透析患者之间)。似乎同时感染HIV-1会增加通过母婴传播或性传播途径感染HCV的风险。